LivaNova PLC
LIVN
View Detailed Chart
61.850USD
-1.800-2.83%
Close 03/27, 16:00（ET）Quotes delayed by 15 min
1.74BMarket Cap
LossP/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
-2.83%
5 Days
-0.55%
1 Month
-12.39%
6 Months
+15.74%
Year to Date
+0.52%
1 Year
+56.11%
View Detailed Chart
TradingKey Stock Score of LivaNova PLC
Currency: USD Updated: 2026-03-27Key Insights
LivaNova PLC's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 11 out of 208 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 78.67.In the medium term, the stock price is expected to remain stable.Despite a weak stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
LivaNova PLC's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Negative
LivaNova PLC Highlights
StrengthsRisks
LivaNova PLC is a medical technology company. The Company designs, develops, manufactures, markets and sells products and therapies. Its segments include Cardiopulmonary, and Neuromodulation. Its Cardiopulmonary segment is engaged in the design, development, manufacture, marketing, and sale of cardiopulmonary products, including heart-lung machines (HLM), oxygenators, autotransfusion systems, perfusion tubing systems, cannula, and other related accessories. Its Neuromodulation segment is engaged in the design, development, manufacture, marketing, and sale of devices that deliver neuromodulation therapy for treating drug-resistant epilepsy (DRE) and difficult-to-treat depression (DTD). Its principal Neuromodulation product, the VNS Therapy System, consists of an implantable pulse generator and connective lead that stimulates the vagus nerve, surgical equipment to assist with the implant procedure, and equipment and instruction manuals.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 20.33% year-on-year.
Turnaround to Loss
The company's performance has turned to a loss, with the latest annual loss of USD .
Fairly Valued
The company’s latest PE is -13.91, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 58.07M shares, decreasing 15.41% quarter-over-quarter.
Held by HACAX
Star Investor HACAX holds 31.43K shares of this stock.
Analyst Rating
Based on
11
analysts
Buy
Current Rating
78.665
Target Price
+26.07%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
LivaNova PLC News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
LivaNova PLC Info
LivaNova PLC is a medical technology company. The Company designs, develops, manufactures, markets and sells products and therapies. Its segments include Cardiopulmonary, and Neuromodulation. Its Cardiopulmonary segment is engaged in the design, development, manufacture, marketing, and sale of cardiopulmonary products, including heart-lung machines (HLM), oxygenators, autotransfusion systems, perfusion tubing systems, cannula, and other related accessories. Its Neuromodulation segment is engaged in the design, development, manufacture, marketing, and sale of devices that deliver neuromodulation therapy for treating drug-resistant epilepsy (DRE) and difficult-to-treat depression (DTD). Its principal Neuromodulation product, the VNS Therapy System, consists of an implantable pulse generator and connective lead that stimulates the vagus nerve, surgical equipment to assist with the implant procedure, and equipment and instruction manuals.
Ticker SymbolLIVN
CompanyLivaNova PLC
CEOMakatsaria (Vladimir A)
Websitehttps://www.livanova.com/
Related Instruments
-3.37%
-1.76%
-3.17%
-0.55%
-3.39%
-3.47%
-1.58%
-1.43%
-2.67%
-0.60%
-1.55%
-1.75%
-3.72%
-2.61%
-2.01%
-3.36%
-2.86%
-1.52%
-0.91%
-1.82%Popular Symbols
248.800
-4.090 (-1.62%)
167.520
-3.720 (-2.17%)
66411.780
+421.020 (+0.64%)
275.340
+1.990 (+0.73%)
1999.310
+15.770 (+0.80%)
361.830
-10.280 (-2.76%)
4492.520
+112.460 (+2.57%)
100.609
+7.287 (+7.81%)
1.151
-0.002 (-0.17%)
160.252
+0.465 (+0.29%)
